SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011073
Filing Date
2018-08-07
Accepted
2018-08-07 15:33:35
Documents
38
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 338633
2 ex10-22.htm EX-10.22 1169
3 ex10-23.htm EX-10.23 1122
4 image_001.jpg GRAPHIC 3701
5 ex31-1.htm EX-31.1 17410
6 ex31-2.htm EX-31.2 17928
7 ex32-1.htm EX-32.1 8339
8 ex10-22_001.jpg GRAPHIC 230027
9 ex10-23_001.jpg GRAPHIC 115726
  Complete submission text file 0001493152-18-011073.txt   1549375

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE vapa-20180630.xml EX-101.INS 61427
11 XBRL SCHEMA FILE vapa-20180630.xsd EX-101.SCH 13138
12 XBRL CALCULATION FILE vapa-20180630_cal.xml EX-101.CAL 22326
13 XBRL DEFINITION FILE vapa-20180630_def.xml EX-101.DEF 39994
14 XBRL LABEL FILE vapa-20180630_lab.xml EX-101.LAB 96666
15 XBRL PRESENTATION FILE vapa-20180630_pre.xml EX-101.PRE 78626
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

IRS No.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 18997744
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences